Conference
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma (PDAC) (MOBILITY-002 Trial, NCT02428270).
Abstract
409
Authors
Aung KL; McWhirter E; Welch S; Wang L; Lovell S; Stayner L-A; Ali S; Malpage A; Makepeace B; Ramachandran M
Volume
36
Pagination
pp. 409-409
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 1, 2018
DOI
10.1200/jco.2018.36.4_suppl.409
Conference proceedings
Journal of Clinical Oncology
Issue
4_suppl
ISSN
0732-183X